Eyeing India’s biotech industry


The MoU signing ceremony was witnessed by International Trade and Industry Minister Datuk Seri Mustapa Mohamed (sixth from right).

ENTOGENEX Industries Sdn Bhd (EntoGenex) has signed a Memorandum of Understanding (MoU) with the state government of Andhra Pradesh in India, with a view to invest in the state in the areas of biotechnology and vector control, particularly technologies related to the control of disease-carrying mosquitoes.

The signing ceremony was done in conjunction with the Asean-India Business Leadership Conclave 2016, held in the Perdana Hall, Ministry of International Trade Tower on July 21.

The MoU was signed by EntoGenex director Marcus Francis while Minister for Labour and Employment Sri Atchannaidu Kinjarapu inked the paper on behalf of the government of Andhra Pradesh.

“India spends approximately US$3.05bil on malaria and dengue control, a significant amount of which is spent on vector control,” Francis said.

“We are looking forward to helping India, particularly the state of Andhra Pradesh, to control mosquito-borne diseases, through non-toxic innovations developed by EntoGenex,” he added.

“We are proud to have become one of the first Malaysian companies to introduce these toxic-free solutions to combat mosquitoes in India,” he said.

EntoGenex had previously embarked on the Komuniti Bebas Denggi programme (KBD) at home as a technology partner, and the result was a reduction of an average of 54.7% in dengue cases over a three-month implementation period.

This programme, supported by the Science, Technology and Innovation Ministry, involved not only the use of technological innovations, but also methodological innovations to reduce breeding spots and educate the public on mosquitoes.

One important element was to get the community to participate in the prevention of dengue.

“We hope this MoU will open up more doors for our entry into the international market,” Francis said.

“Through this partnership, EntoGenex seeks to enhance the well-being of the people, not only in Andhra Pradesh and Malaysia, but all afflicted countries around the world.

“With the convergence of various diseases such as zika, dengue, yellow fever and other mosquito-borne diseases, this is the right time for us to highlight Malaysian solutions, for the benefit of the world,” he stressed.

EntoGenex prioritises green and sustainable solutions aimed at combating mosquito-transmitted diseases in Malaysia and worldwide.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In News

US military is conducting fresh strikes on Iran
Russia rolls out multiple measures to stabilize domestic fuel market
Trump unexpectedly switches back to old Air Force One, sidelining Qatari jet
U.S. dollar ticks down
Crude futures settle higher
Roundup: Mideast flare-up reignites Europe inflation fears as energy prices jump
UAE leads Arab states in FDI inflows in 2025, report says
Trump to remove Syria from US terrorism sponsor list
Yemen reports 30 dengue-related deaths in H1, warns of rainy season surge
Fatal ICE shooting in Houston sparks demands for transparency, independent investigation

Others Also Read